Peter M A Calverley

Peter M A Calverley

UNVERIFIED PROFILE

Are you Peter M A Calverley?   Register this Author

Register author
Peter M A Calverley

Peter M A Calverley

Publications by authors named "Peter M A Calverley"

Are you Peter M A Calverley?   Register this Author

100Publications

3919Reads

9Profile Views

Genetics, Chronic Obstructive Pulmonary Disease, and the Arrow of Time.

Authors:
Peter M A Calverley Paul P Walker

Am J Respir Crit Care Med 2019 Sep;200(6):654-655

Institute of Ageing and Chronic DiseaseUniversity of LiverpoolLiverpool, United Kingdomand.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1164/rccm.201904-0813EDDOI Listing
September 2019

Regional differences in rate of FEV decline in COPD: lessons from SUMMIT.

Authors:
Bartolomé R Celli Julie A Anderson Robert D Brook Peter M A Calverley Nicholas J Cowans Courtney Crim Fernando Martinez David E Newby Julie Yates Jørgen Vestbo

Eur Respir J 2019 Jun 27;53(6). Epub 2019 Jun 27.

Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, University of Manchester, and Manchester University NHS Foundation Trust, Manchester Academic Health Sciences Centre, Manchester, UK.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1183/13993003.00278-2019DOI Listing
June 2019

Detection of Expiratory Flow Limitation by Forced Oscillations during Non-invasive Ventilation.

Authors:
Emanuela Zannin Biswajit Chakrabarti Leonardo Govoni Pasquale P Pompilio Robert Romano Peter M A Calverley Raffaele L Dellacà

Am J Respir Crit Care Med 2019 Jun 26. Epub 2019 Jun 26.

Politecnico di Milano, 18981, Dipartimento di Elettronica, Informazione e Bioingegneria, Milano, Lombardia, Italy.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1164/rccm.201903-0570LEDOI Listing
June 2019

Impact of smoking status and concomitant medications on the effect of high-dose N-acetylcysteine on chronic obstructive pulmonary disease exacerbations: A post-hoc analysis of the PANTHEON study.

Authors:
Alberto Papi Jinping Zheng Gerard J Criner Leonardo M Fabbri Peter M A Calverley

Respir Med 2019 Feb 9;147:37-43. Epub 2019 Jan 9.

School of Aging and Chronic Disease, University of Liverpool, Liverpool, UK.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.rmed.2018.12.014DOI Listing
February 2019

Impact of pre-enrolment medication use on clinical outcomes in SUMMIT.

Authors:
Jørgen Vestbo Mark Dransfield Julie A Anderson Robert D Brook Peter M A Calverley Bartolome R Celli Nicholas J Cowans Courtney Crim Fernando Martinez David E Newby Julie Yates Peter Lange

ERJ Open Res 2019 Feb 25;5(1). Epub 2019 Feb 25.

Dept of Public Health, Section of Social Medicine, University of Copenhagen, Copenhagen, Denmark.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1183/23120541.00203-2018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6387990PMC
February 2019

Fibrinogen does not relate to cardiovascular or muscle manifestations in COPD: cross-sectional data from the ERICA study.

Authors:
Divya Mohan Julia R Forman Matthew Allinder Carmel M McEniery Charlotte Emma Bolton John R Cockcroft William MacNee Jonathan Fuld Mellone Marchong Nichola Sian Gale Marie Fisk Sridevi Nagarajan Joseph Cheriyan David A Lomas Peter M A Calverley Bruce E Miller Ruth Tal-Singer Ian B Wilkinson Michael I Polkey

Thorax 2018 12 4;73(12):1182-1185. Epub 2018 Apr 4.

NIHR Respiratory Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust, Imperial College, London, UK.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1136/thoraxjnl-2018-211556DOI Listing
December 2018

Lung Function through the PRISm. Spreading Light or Creating Confusion?

Authors:
Bo Lundbäck Helena Backman Peter M A Calverley

Am J Respir Crit Care Med 2018 12;198(11):1358-1360

3 Academy of Medical Sciences University of Liverpool Liverpool, United Kingdom.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1164/rccm.201806-1163EDDOI Listing
December 2018

Spirometric changes during exacerbations of COPD: a post hoc analysis of the WISDOM trial.

Authors:
Henrik Watz Kay Tetzlaff Helgo Magnussen Achim Mueller Roberto Rodriguez-Roisin Emiel F M Wouters Claus Vogelmeier Peter M A Calverley

Respir Res 2018 Dec 13;19(1):251. Epub 2018 Dec 13.

Institute of Ageing and Chronic Disease, Clinical Science Centre, University Hospital Aintree, Liverpool, UK.

View Article

Download full-text PDF

 Source
https://respiratory-research.biomedcentral.com/articles/10.1
Publisher Site
http://dx.doi.org/10.1186/s12931-018-0944-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6293570PMC
December 2018

Determinants of Response to Roflumilast in Severe Chronic Obstructive Pulmonary Disease. Pooled Analysis of Two Randomized Trials.

Authors:
Fernando J Martinez Klaus F Rabe Peter M A Calverley Leonardo M Fabbri Sanjay Sethi Emilio Pizzichini Andrew McIvor Antonio Anzueto Vijay K T Alagappan Shahid Siddiqui Colin Reisner Sofia Zetterstrand Jonas Román Debasree Purkayastha Nitin Bagul Stephen I Rennard

Am J Respir Crit Care Med 2018 11;198(10):1268-1278

14 University of Nebraska Medical Center, Omaha, Nebraska; and.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1164/rccm.201712-2493OCDOI Listing
November 2018

Whole exome sequencing analysis in severe chronic obstructive pulmonary disease.

Authors:
Dandi Qiao Asher Ameli Dmitry Prokopenko Han Chen Alvin T Kho Margaret M Parker Jarrett Morrow Brian D Hobbs Yanhong Liu Terri H Beaty James D Crapo Kathleen C Barnes Deborah A Nickerson Michael Bamshad Craig P Hersh David A Lomas Alvar Agusti Barry J Make Peter M A Calverley Claudio F Donner Emiel F Wouters Jørgen Vestbo Peter D Paré Robert D Levy Stephen I Rennard Ruth Tal-Singer Margaret R Spitz Amitabh Sharma Ingo Ruczinski Christoph Lange Edwin K Silverman Michael H Cho

Hum Mol Genet 2018 11;27(21):3801-3812

Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1093/hmg/ddy269DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196654PMC
November 2018

Safety of tiotropium/olodaterol in chronic obstructive pulmonary disease: pooled analysis of three large, 52-week, randomized clinical trials.

Authors:
Gary T Ferguson Roland Buhl Ulrich Bothner Alberto de la Hoz Florian Voß Antonio Anzueto Peter M A Calverley

Respir Med 2018 10 28;143:67-73. Epub 2018 Aug 28.

Clinical Science Centre, Institute of Ageing and Chronic Disease, University of Liverpool, 6 West Derby Street, Liverpool, L7 8TX, UK. Electronic address:

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.rmed.2018.08.012DOI Listing
October 2018

Telemonitoring in Chronic Obstructive Pulmonary Disease (CHROMED). A Randomized Clinical Trial.

Authors:
Paul P Walker Pasquale P Pompilio Paolo Zanaboni Trine S Bergmo Kaiu Prikk Andrei Malinovschi Josep M Montserrat Jo Middlemass Silvana Šonc Giulia Munaro Dorjan Marušič Ruth Sepper Roberto Rosso A Niroshan Siriwardena Christer Janson Ramon Farré Peter M A Calverley Raffaele L Dellaca'

Am J Respir Crit Care Med 2018 09;198(5):620-628

3 Restech s.r.l., Milano, Italy.

View Article

Download full-text PDF

 Source
https://www.atsjournals.org/doi/10.1164/rccm.201712-2404OC
Publisher Site
http://dx.doi.org/10.1164/rccm.201712-2404OCDOI Listing
September 2018

Blood pressure, heart rate, and mortality in chronic obstructive pulmonary disease: the SUMMIT trial.

Authors:
James Brian Byrd David E Newby Julie A Anderson Peter M A Calverley Bartolome R Celli Nicholas J Cowans Courtney Crim Fernando J Martinez Jørgen Vestbo Julie Yates Robert D Brook

Eur Heart J 2018 09;39(33):3128-3134

University of Michigan Health System, 1500 E Medical Center Dr, Ann Arbor, MI 48109, USA.

View Article

Download full-text PDF

 Source
https://academic.oup.com/eurheartj/article/39/33/3128/506764
Publisher Site
http://dx.doi.org/10.1093/eurheartj/ehy451DOI Listing
September 2018

Cardiac Troponin I and Cardiovascular Risk in Patients With Chronic Obstructive Pulmonary Disease.

Authors:
Philip D Adamson Julie A Anderson Robert D Brook Peter M A Calverley Bartolome R Celli Nicholas J Cowans Courtney Crim Ian J Dixon Fernando J Martinez David E Newby Jørgen Vestbo Julie C Yates Nicholas L Mills

J Am Coll Cardiol 2018 09;72(10):1126-1137

British Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom. Electronic address:

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.jacc.2018.06.051DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6119211PMC
September 2018

Exacerbations of Chronic Obstructive Pulmonary Disease and Cardiac Events. A Post Hoc Cohort Analysis from the SUMMIT Randomized Clinical Trial.

Authors:
Ken M Kunisaki Mark T Dransfield Julie A Anderson Robert D Brook Peter M A Calverley Bartolome R Celli Courtney Crim Benjamin F Hartley Fernando J Martinez David E Newby Alexa A Pragman Jørgen Vestbo Julie C Yates Dennis E Niewoehner

Am J Respir Crit Care Med 2018 07;198(1):51-57

1 Minneapolis Veterans Affairs Health Care System, Minneapolis, Minnesota.

View Article

Download full-text PDF

 Source
https://www.atsjournals.org/doi/10.1164/rccm.201711-2239OC
Publisher Site
http://dx.doi.org/10.1164/rccm.201711-2239OCDOI Listing
July 2018

At the Root: Defining and Halting Progression of Early Chronic Obstructive Pulmonary Disease.

Authors:
Fernando J Martinez MeiLan K Han James P Allinson R Graham Barr Richard C Boucher Peter M A Calverley Bartolome R Celli Stephanie A Christenson Ronald G Crystal Malin Fagerås Christine M Freeman Lars Groenke Eric A Hoffman Mehmet Kesimer Kostantinos Kostikas Robert Paine Shahin Rafii Stephen I Rennard Leopoldo N Segal Renat Shaykhiev Christopher Stevenson Ruth Tal-Singer Jørgen Vestbo Prescott G Woodruff Jeffrey L Curtis Jadwiga A Wedzicha

Am J Respir Crit Care Med 2018 06;197(12):1540-1551

3 Imperial College, London, United Kingdom.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1164/rccm.201710-2028PPDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6006401PMC
June 2018

β-Blocker Therapy and Clinical Outcomes in Patients with Moderate Chronic Obstructive Pulmonary Disease and Heightened Cardiovascular Risk. An Observational Substudy of SUMMIT.

Authors:
Mark T Dransfield David A McAllister Julie A Anderson Robert D Brook Peter M A Calverley Bartolome R Celli Courtney Crim Natacha Gallot Fernando J Martinez Paul D Scanlon Julie Yates Jørgen Vestbo David E Newby

Ann Am Thorac Soc 2018 05;15(5):608-614

12 Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1513/AnnalsATS.201708-626OCDOI Listing
May 2018

Tiotropium and olodaterol in the prevention of chronic obstructive pulmonary disease exacerbations (DYNAGITO): a double-blind, randomised, parallel-group, active-controlled trial.

Authors:
Peter M A Calverley Antonio R Anzueto Kerstine Carter Lars Grönke Christoph Hallmann Christine Jenkins Jadwiga Wedzicha Klaus F Rabe

Lancet Respir Med 2018 05 5;6(5):337-344. Epub 2018 Apr 5.

LungClinic Grosshansdorf, Grosshansdorf, Germany.

View Article

Download full-text PDF

 Source
https://linkinghub.elsevier.com/retrieve/pii/S22132600183010
Publisher Site
http://dx.doi.org/10.1016/S2213-2600(18)30102-4DOI Listing
May 2018

Demographic Characteristics and Clinical Outcomes in Patients from Latin America Versus the Rest of the World: A TIOSPIR Post-Hoc Analysis.

Authors:
Antonio Anzueto Peter M A Calverley Achim Mueller Norbert Metzdorf Michaela Haensel José R Jardim Emilio Pizzichini Horacio Giraldo Alejandra Ramirez-Venegas Eduardo R Giugno

Arch Bronconeumol 2018 Mar 6;54(3):140-148. Epub 2018 Jan 6.

Hospital Zonal Especializado de Agudos y Crónicos "Dr. Antonio Cetrángolo", Buenos Aires, Argentina.

View Article

Download full-text PDF

 Source
https://linkinghub.elsevier.com/retrieve/pii/S03002896173042
Publisher Site
http://dx.doi.org/10.1016/j.arbres.2017.11.010DOI Listing
March 2018

The Effect of Defining Chronic Obstructive Pulmonary Disease by the Lower Limit of Normal of FEV/FVC Ratio in Tiotropium Safety and Performance in Respimat Participants.

Authors:
Peter M A Calverley Achim Mueller Andrew Fowler Norbert Metzdorf Robert A Wise

Ann Am Thorac Soc 2018 02;15(2):200-208

5 Johns Hopkins University School of Medicine, Baltimore, Maryland.

View Article

Download full-text PDF

 Source
http://www.atsjournals.org/doi/10.1513/AnnalsATS.201703-194O
Publisher Site
http://dx.doi.org/10.1513/AnnalsATS.201703-194OCDOI Listing
February 2018

Fluticasone Furoate, Vilanterol, and Lung Function Decline in Patients with Moderate Chronic Obstructive Pulmonary Disease and Heightened Cardiovascular Risk.

Authors:
Peter M A Calverley Julie A Anderson Robert D Brook Courtney Crim Natacha Gallot Sally Kilbride Fernando J Martinez Julie Yates David E Newby Jørgen Vestbo Robert Wise Bartolomé R Celli

Am J Respir Crit Care Med 2018 01;197(1):47-55

11 Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1164/rccm.201610-2086OCDOI Listing
January 2018

Pulmonary rehabilitation for patients with COPD during and after an exacerbation-related hospitalisation: back to the future?

Authors:
Kevin C Wilson Jerry A Krishnan Pawel Sliwinski Gerard J Criner Marc Miravitlles John R Hurst Peter M A Calverley Richard K Albert David Rigau Thomy Tonia Jørgen Vestbo Alberto Papi Klaus F Rabe Antonio Anzueto Jadwiga A Wedzicha

Eur Respir J 2018 01 11;51(1). Epub 2018 Jan 11.

Airways Disease Section, National Heart and Lung Institute, Imperial College London, UK; co-chair, representing the European Respiratory Society.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1183/13993003.02577-2017DOI Listing
January 2018

Cigarette smoking and response to inhaled corticosteroids in COPD.

Authors:
Surya P Bhatt Julie A Anderson Robert D Brook Peter M A Calverley Bartolome R Celli Nicholas J Cowans Courtney Crim Fernando J Martinez David E Newby Jørgen Vestbo Julie C Yates Mark T Dransfield

Eur Respir J 2018 01 18;51(1). Epub 2018 Jan 18.

Division of Pulmonary, Allergy and Critical Care Medicine and Lung Health Center, University of Alabama at Birmingham, Birmingham, AL, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1183/13993003.01393-2017DOI Listing
January 2018

Triple Therapy in COPD: What We Know and What We Don't.

Authors:
Peter M A Calverley Helgo Magnussen Marc Miravitlles Jadwiga A Wedzicha

COPD 2017 Dec 9;14(6):648-662. Epub 2017 Nov 9.

d Airways Disease Section , National Heart and Lung Institute, Imperial College London , London , UK.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1080/15412555.2017.1389875DOI Listing
December 2017

Eosinophilia, Frequent Exacerbations, and Steroid Response in Chronic Obstructive Pulmonary Disease.

Authors:
Peter M A Calverley Kay Tetzlaff Claus Vogelmeier Leonardo M Fabbri Helgo Magnussen Emiel F M Wouters William Mezzanotte Bernd Disse Helen Finnigan Guus Asijee Christoph Hallmann Henrik Watz

Am J Respir Crit Care Med 2017 11;196(9):1219-1221

6 Lung Clinic Grosshansdorf, Airway Research Center North Grosshansdorf, Germany.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1164/rccm.201612-2525LEDOI Listing
November 2017

Where to start when treating COPD?

Authors:
Peter M A Calverley

Respirology 2017 10 16;22(7):1239-1240. Epub 2017 Jul 16.

Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, UK.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1111/resp.13126DOI Listing
October 2017

Pneumonia risk with inhaled fluticasone furoate and vilanterol in COPD patients with moderate airflow limitation: The SUMMIT trial.

Authors:
Courtney Crim Peter M A Calverley Julie A Anderson Andrew P Holmes Sally Kilbride Fernando J Martinez Robert D Brook David E Newby Julie C Yates Bartolomé R Celli Jørgen Vestbo

Respir Med 2017 10 1;131:27-34. Epub 2017 Aug 1.

University of Manchester and University Hospital South Manchester NHS Foundation Trust, Manchester, UK.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.rmed.2017.07.060DOI Listing
October 2017

Effect of erdosteine on the rate and duration of COPD exacerbations: the RESTORE study.

Authors:
Roberto W Dal Negro Jadwiga A Wedzicha Martin Iversen Giovanni Fontana Clive Page Arrigo F Cicero Edoardo Pozzi Peter M A Calverley

Eur Respir J 2017 10 12;50(4). Epub 2017 Oct 12.

Dept of Medicine, Clinical Sciences Centre, University Hospital Aintree, Liverpool, UK.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1183/13993003.00711-2017DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678897PMC
October 2017

Prevention of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline.

Authors:
Jadwiga A Wedzicha Peter M A Calverley Richard K Albert Antonio Anzueto Gerard J Criner John R Hurst Marc Miravitlles Alberto Papi Klaus F Rabe David Rigau Pawel Sliwinski Thomy Tonia Jørgen Vestbo Kevin C Wilson Jerry A Krishnan

Eur Respir J 2017 09 9;50(3). Epub 2017 Sep 9.

University of Illinois Hospital and Health Sciences System, Chicago, IL, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1183/13993003.02265-2016DOI Listing
September 2017

Breathlessness despite optimal pathophysiological treatment: on the relevance of being chronic.

Authors:
Peter M A Calverley

Eur Respir J 2017 09 27;50(3). Epub 2017 Sep 27.

Clinical Science, University Hospital Aintree, Liverpool, UK

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1183/13993003.01376-2017DOI Listing
September 2017

Analysis of nocturnal actigraphic sleep measures in patients with COPD and their association with daytime physical activity.

Authors:
Gabriele Spina Martijn A Spruit Jennifer Alison Roberto P Benzo Peter M A Calverley Christian F Clarenbach Richard W Costello David Donaire-Gonzalez Selina Dürr Judith Garcia-Aymerich Arnoldus J R van Gestel Marco Gramm Nidia A Hernandes Kylie Hill Nicholas S Hopkinson Diana Jarreta Malcolm Kohler Anne M Kirsten Jörg D Leuppi Helgo Magnussen François Maltais William D-C Man Zoe J McKeough Rafael Mesquita David Miedinger Fabio Pitta Sally J Singh Frank W J M Smeenk Ruth Tal-Singer Barbara Vagaggini Benjamin Waschki Henrik Watz Emiel F M Wouters Stefanie Zogg Albertus C den Brinker

Thorax 2017 08 12;72(8):694-701. Epub 2017 Jan 12.

Data Science Group, Philips Research, Eindhoven, The Netherlands.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1136/thoraxjnl-2016-208900DOI Listing
August 2017

A randomised, placebo-controlled trial of anti-interleukin-1 receptor 1 monoclonal antibody MEDI8968 in chronic obstructive pulmonary disease.

Authors:
Peter M A Calverley Sanjay Sethi Michelle Dawson Christine K Ward Donna K Finch Mark Penney Paul Newbold René van der Merwe

Respir Res 2017 08 9;18(1):153. Epub 2017 Aug 9.

MedImmune, Cambridge, UK.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1186/s12931-017-0633-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5551010PMC
August 2017

Effect of roflumilast in patients with severe COPD and a history of hospitalisation.

Authors:
Klaus F Rabe Peter M A Calverley Fernando J Martinez Leonardo M Fabbri

Eur Respir J 2017 07 5;50(1). Epub 2017 Jul 5.

University of Modena and Reggio Emilia, Modena, Italy.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1183/13993003.00158-2017DOI Listing
July 2017

Effect of Home Noninvasive Ventilation With Oxygen Therapy vs Oxygen Therapy Alone on Hospital Readmission or Death After an Acute COPD Exacerbation: A Randomized Clinical Trial.

Authors:
Patrick B Murphy Sunita Rehal Gill Arbane Stephen Bourke Peter M A Calverley Angela M Crook Lee Dowson Nicholas Duffy G John Gibson Philip D Hughes John R Hurst Keir E Lewis Rahul Mukherjee Annabel Nickol Nicholas Oscroft Maxime Patout Justin Pepperell Ian Smith John R Stradling Jadwiga A Wedzicha Michael I Polkey Mark W Elliott Nicholas Hart

JAMA 2017 06;317(21):2177-2186

Lane Fox Unit, Guy's and St Thomas' NHS Foundation Trust, London, England2Asthma, Allergy, and Lung Biology, King's College London, London, England.

View Article

Download full-text PDF

 Source
http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.20
Publisher Site
http://dx.doi.org/10.1001/jama.2017.4451DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5710342PMC
June 2017

AJRCCM: 100-Year Anniversary. Physiology and Chronic Obstructive Pulmonary Disease in the Blue Journals.

Authors:
Peter M A Calverley

Am J Respir Crit Care Med 2017 May;195(9):1088-1090

1 Institute of Ageing and Chronic Disease University of Liverpool Liverpool, United Kingdom.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1164/rccm.201701-0114EDDOI Listing
May 2017

A Light in the Darkness? The FLAME Trial, Blood Eosinophils, and Chronic Obstructive Pulmonary Disease.

Authors:
Peter M A Calverley

Am J Respir Crit Care Med 2017 05;195(9):1125-1127

1 Institute of Ageing and Chronic Disease University of Liverpool Liverpool, United Kingdom.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1164/rccm.201703-0560EDDOI Listing
May 2017

Chronic breathlessness: symptom or syndrome?

Authors:
Peter M A Calverley

Eur Respir J 2017 05 25;49(5). Epub 2017 May 25.

School of Ageing and Chronic Disease, University Hospital Aintree, Liverpool, UK

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1183/13993003.00366-2017DOI Listing
May 2017

Effect of Fluticasone Furoate and Vilanterol on Exacerbations of Chronic Obstructive Pulmonary Disease in Patients with Moderate Airflow Obstruction.

Authors:
Fernando J Martinez Jørgen Vestbo Julie A Anderson Robert D Brook Bartolome R Celli Nicholas J Cowans Courtney Crim Mark Dransfield Sally Kilbride Julie Yates David E Newby Dennis Niewoehner Peter M A Calverley

Am J Respir Crit Care Med 2017 04;195(7):881-888

11 University of Liverpool, Department of Medicine, Clinical Sciences Centre, University Hospital Aintree, Liverpool, United Kingdom.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1164/rccm.201607-1421OCDOI Listing
April 2017

Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline.

Authors:
Jadwiga A Wedzicha Marc Miravitlles John R Hurst Peter M A Calverley Richard K Albert Antonio Anzueto Gerard J Criner Alberto Papi Klaus F Rabe David Rigau Pawel Sliwinski Thomy Tonia Jørgen Vestbo Kevin C Wilson Jerry A Krishnan

Eur Respir J 2017 03 15;49(3). Epub 2017 Mar 15.

University of Illinois Hospital and Health Sciences System, Chicago, IL, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1183/13993003.00791-2016DOI Listing
March 2017

Chronic Obstructive Pulmonary Disease Exacerbations and Lung Function Decline. Mechanism or Marker?

Authors:
Peter M A Calverley

Am J Respir Crit Care Med 2017 02;195(3):278-279

1 Institute of Ageing and Chronic Disease University of Liverpool Liverpool, United Kingdom.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1164/rccm.201609-1837EDDOI Listing
February 2017

Through a glass darkly: inhaled corticosteroids, airway inflammation and COPD.

Authors:
Peter M A Calverley

Eur Respir J 2017 01 3;49(1). Epub 2017 Jan 3.

Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, UK

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1183/13993003.02201-2016DOI Listing
January 2017

Determinants of exercise-induced oxygen desaturation including pulmonary emphysema in COPD: Results from the ECLIPSE study.

Authors:
Vasileios Andrianopoulos Bartolome R Celli Frits M E Franssen Victor M Pinto-Plata Peter M A Calverley Lowie E G W Vanfleteren Ioannis Vogiatzis Jørgen Vestbo Alvar Agusti Per S Bakke Stephen I Rennard William MacNee Ruth Tal-Singer Julie C Yates Emiel F M Wouters Martijn A Spruit

Respir Med 2016 10 25;119:87-95. Epub 2016 Aug 25.

Department of Research and Education, CIRO+, Centre of Expertise for Chronic Organ Failure, Horn, The Netherlands; REVAL - Rehabilitation Research Center, BIOMED - Biomedical Research Institute, Faculty of Medicine and Life Sciences, Hasselt University, Diepenbeek, Belgium. Electronic address:

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.rmed.2016.08.023DOI Listing
October 2016

COPD therapy: if two is good, is three better?

Authors:
Peter M A Calverley

Lancet 2016 Sep 1;388(10048):937-8. Epub 2016 Sep 1.

School of Ageing and Chronic Disease, University of Liverpool, Liverpool L69 3BX, UK. Electronic address:

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/S0140-6736(16)31464-7DOI Listing
September 2016

Sarcopenic Obesity, Functional Outcomes, and Systemic Inflammation in Patients With Chronic Obstructive Pulmonary Disease.

Authors:
Pavol Joppa Ruzena Tkacova Frits M E Franssen Corrine Hanson Stephen I Rennard Edwin K Silverman Merry-Lynn N McDonald Peter M A Calverley Ruth Tal-Singer Martijn A Spruit Klaus Kenn Emiel F M Wouters Erica P A Rutten

J Am Med Dir Assoc 2016 08 5;17(8):712-8. Epub 2016 May 5.

Department of Research and Education, CIRO, Horn, Netherlands.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.jamda.2016.03.020DOI Listing
August 2016

Blood eosinophils as a marker of response to inhaled corticosteroids in COPD.

Authors:
Neil C Barnes Raj Sharma Sally Lettis Peter M A Calverley

Eur Respir J 2016 05 25;47(5):1374-82. Epub 2016 Feb 25.

Respiratory Research Dept, University of Liverpool, Liverpool, UK.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1183/13993003.01370-2015DOI Listing
May 2016

Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial.

Authors:
Henrik Watz Kay Tetzlaff Emiel F M Wouters Anne Kirsten Helgo Magnussen Roberto Rodriguez-Roisin Claus Vogelmeier Leonardo M Fabbri Pascal Chanez Ronald Dahl Bernd Disse Helen Finnigan Peter M A Calverley

Lancet Respir Med 2016 05 7;4(5):390-8. Epub 2016 Apr 7.

Institute of Ageing and Chronic Disease, Aintree University Hospital, Liverpool, UK.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/S2213-2600(16)00100-4DOI Listing
May 2016

Tiotropium Respimat(®) Versus HandiHaler(®): Comparison of Bronchodilator Efficacy of Various Doses in Clinical Trials.

Authors:
Peter M A Calverley Michael Könen-Bergmann Frank Richard Susan Bell Jens M Hohlfeld

Adv Ther 2016 05 28;33(5):786-93. Epub 2016 Mar 28.

Clinical Airway Research, Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM), Hannover, Germany.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1007/s12325-016-0322-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4882367PMC
May 2016

Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trial.

Authors:
Jørgen Vestbo Julie A Anderson Robert D Brook Peter M A Calverley Bartolome R Celli Courtney Crim Fernando Martinez Julie Yates David E Newby

Lancet 2016 Apr 28;387(10030):1817-26. Epub 2016 Apr 28.

Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/S0140-6736(16)30069-1DOI Listing
April 2016

Effect of tiotropium on night-time awakening and daily rescue medication use in patients with COPD.

Authors:
Peter M A Calverley Stephen I Rennard Emmanuelle Clerisme-Beaty Norbert Metzdorf Valentina Bayer Zubek Richard ZuWallack

Respir Res 2016 Mar 12;17:27. Epub 2016 Mar 12.

St Francis Hospital Medical Center, Hartford, CT, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1186/s12931-016-0340-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789269PMC
March 2016

Lung function changes over time following withdrawal of inhaled corticosteroids in patients with severe COPD.

Authors:
Helgo Magnussen Kay Tetzlaff Eric D Bateman Henrik Watz Anne M Kirsten Emiel F M Wouters Bernd Disse Helen Finnigan Roberto Rodriguez-Roisin Peter M A Calverley

Eur Respir J 2016 Feb 19;47(2):651-4. Epub 2015 Nov 19.

Institute of Ageing and Chronic Disease, Aintree University Hospital, Liverpool, UK.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1183/13993003.01644-2015DOI Listing
February 2016

Safety and efficacy of tiotropium in patients switching from HandiHaler to Respimat in the TIOSPIR trial.

Authors:
Ronald Dahl Peter M A Calverley Antonio Anzueto Norbert Metzdorf Andy Fowler Achim Mueller Robert Wise Daniel Dusser

BMJ Open 2015 Dec 29;5(12):e009015. Epub 2015 Dec 29.

Department of Pneumology, Hôpital Cochin, AP-HP, Université Paris Descartes, Paris, France.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1136/bmjopen-2015-009015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4710815PMC
December 2015

The Association Between Heroin Inhalation and Early Onset Emphysema.

Authors:
Paul P Walker Erica Thwaite Suzanne Amin John M Curtis Peter M A Calverley

Chest 2015 Nov;148(5):1156-1163

University Hospital Aintree, Liverpool, England.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1378/chest.15-0236DOI Listing
November 2015

Continuous fat-free mass decline in COPD: fact or fiction?

Authors:
Erica P A Rutten Martijn A Spruit Merry-Lynn N McDonald Stephen Rennard Alvar Agusti Bartolome Celli Bruce E Miller Courtney Crim Peter M A Calverley Corrine Hanson William MacNee Frits M E Franssen Lowie Vanfleteren Emiel F M Wouters

Eur Respir J 2015 Nov 17;46(5):1496-8. Epub 2015 Sep 17.

Dept of Research and Education, CIRO, Horn, The Netherlands Maastricht University Medical Center, Maastricht, The Netherlands.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1183/13993003.00692-2015DOI Listing
November 2015

Safety and efficacy of tiotropium Respimat versus HandiHaler in patients naive to treatment with inhaled anticholinergics: a post hoc analysis of the TIOSPIR trial.

Authors:
Robert Wise Peter M A Calverley Ronald Dahl Daniel Dusser Norbert Metzdorf Achim Müller Andy Fowler Antonio Anzueto

NPJ Prim Care Respir Med 2015 Nov 5;25:15067. Epub 2015 Nov 5.

Department of Medicine, Pulmonary Critical Care Center, University of Texas Health Science Center, San Antonio, TX, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1038/npjpcrm.2015.67DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634206PMC
November 2015

Effects of different antibiotic classes on airway bacteria in stable COPD using culture and molecular techniques: a randomised controlled trial.

Authors:
Simon E Brill Martin Law Ethaar El-Emir James P Allinson Phillip James Victoria Maddox Gavin C Donaldson Timothy D McHugh William O Cookson Miriam F Moffatt Irwin Nazareth John R Hurst Peter M A Calverley Michael J Sweeting Jadwiga A Wedzicha

Thorax 2015 Oct 15;70(10):930-8. Epub 2015 Jul 15.

National Heart and Lung Institute, Imperial College London, London, UK.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1136/thoraxjnl-2015-207194DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602260PMC
October 2015

Predicting loss of lung function in healthy people.

Authors:
Peter M A Calverley

Lancet Respir Med 2015 Aug 6;3(8):590-1. Epub 2015 Jul 6.

School of Ageing and Chronic Disease, University Hospital Aintree, Liverpool L97AL, UK. Electronic address:

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/S2213-2600(15)00236-2DOI Listing
August 2015

Large trials, new knowledge: the changing face of COPD management.

Authors:
Anthony De Soyza Peter M A Calverley

Eur Respir J 2015 Jun 18;45(6):1692-703. Epub 2015 Mar 18.

Department of Clinical Sciences, University of Liverpool, University Hospital Aintree, Liverpool, UK

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1183/09031936.00179714DOI Listing
June 2015

Variability of within-breath reactance in COPD patients and its association with dyspnoea.

Authors:
Bernt B Aarli Peter M A Calverley Robert L Jensen Tomas M L Eagan Per S Bakke Jon A Hardie

Eur Respir J 2015 Mar 30;45(3):625-34. Epub 2014 Oct 30.

Institute of Clinical Science, University of Bergen, Bergen, Norway.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1183/09031936.00051214DOI Listing
March 2015

Identification of five chronic obstructive pulmonary disease subgroups with different prognoses in the ECLIPSE cohort using cluster analysis.

Authors:
Stephen I Rennard Nicholas Locantore Bruno Delafont Ruth Tal-Singer Edwin K Silverman Jørgen Vestbo Bruce E Miller Per Bakke Bartolomé Celli Peter M A Calverley Harvey Coxson Courtney Crim Lisa D Edwards David A Lomas William MacNee Emiel F M Wouters Julie C Yates Ignacio Coca Alvar Agustí

Ann Am Thorac Soc 2015 Mar;12(3):303-12

1 Pulmonary and Critical Care Medicine, University of Nebraska Medical Center, Omaha, Nebraska.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1513/AnnalsATS.201403-125OCDOI Listing
March 2015

Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trial.

Authors:
Fernando J Martinez Peter M A Calverley Udo-Michael Goehring Manja Brose Leonardo M Fabbri Klaus F Rabe

Lancet 2015 Mar 13;385(9971):857-66. Epub 2015 Feb 13.

LungenClinic Grosshansdorf, Airway Research Center North, Member of the German Center for Lung Research (DZL), Grosshansdorf, Germany; Department of Medicine, Christian-Albrechts University Kiel, Kiel, Germany.

View Article

Download full-text PDF

 Source
http://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(
Web Search
http://linkinghub.elsevier.com/retrieve/pii/S014067361462410
Publisher Site
http://dx.doi.org/10.1016/S0140-6736(14)62410-7DOI Listing
March 2015

Roflumilast and dyspnea in patients with moderate to very severe chronic obstructive pulmonary disease: a pooled analysis of four clinical trials.

Authors:
Stephen I Rennard Shawn X Sun Stavros Tourkodimitris Paul Rowe Udo M Goehring Dirk Bredenbröker Peter M A Calverley

Int J Chron Obstruct Pulmon Dis 2014 24;9:657-73. Epub 2014 Jun 24.

Department of Clinical Science, University of Liverpool, Liverpool, UK.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.2147/COPD.S55738DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4075954PMC
February 2015

Pneumonia risk with inhaled fluticasone furoate and vilanterol compared with vilanterol alone in patients with COPD.

Authors:
Courtney Crim Mark T Dransfield Jean Bourbeau Paul W Jones Nicola A Hanania Donald A Mahler Jørgen Vestbo Andrew Wachtel Fernando J Martinez Frank Barnhart Sally Lettis Peter M A Calverley

Ann Am Thorac Soc 2015 Jan;12(1):27-34

1 GSK, Research Triangle Park, North Carolina.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1513/AnnalsATS.201409-413OCDOI Listing
January 2015

Inhaled glucocorticoids and COPD exacerbations.

Authors:
Helgo Magnussen Kay Tetzlaff Peter M A Calverley

N Engl J Med 2015 01;372(1):93-4

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1056/NEJMc1413308DOI Listing
January 2015

What to use INSTEAD of inhaled corticosteroids in COPD?

Authors:
Peter M A Calverley

Eur Respir J 2014 Dec;44(6):1391-3

School of Ageing and Chronic Disease, University of Liverpool, Liverpool, UK

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1183/09031936.00181114DOI Listing
December 2014

Common genetic variants associated with resting oxygenation in chronic obstructive pulmonary disease.

Authors:
Merry-Lynn N McDonald Michael H Cho Inga-Cecilie Sørheim Sharon M Lutz Peter J Castaldi David A Lomas Harvey O Coxson Lisa D Edwards William MacNee Jørgen Vestbo Julie C Yates Alvar Agusti Peter M A Calverley Bartolome Celli Courtney Crim Stephen I Rennard Emiel F M Wouters Per Bakke Ruth Tal-Singer Bruce E Miller Amund Gulsvik Richard Casaburi J Michael Wells Elizabeth A Regan Barry J Make John E Hokanson Christoph Lange James D Crapo Terri H Beaty Edwin K Silverman Craig P Hersh

Am J Respir Cell Mol Biol 2014 Nov;51(5):678-87

1 Channing Division of Network Medicine, and.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1165/rcmb.2014-0135OCDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224086PMC
November 2014

Withdrawal of inhaled glucocorticoids and exacerbations of COPD.

Authors:
Helgo Magnussen Bernd Disse Roberto Rodriguez-Roisin Anne Kirsten Henrik Watz Kay Tetzlaff Lesley Towse Helen Finnigan Ronald Dahl Marc Decramer Pascal Chanez Emiel F M Wouters Peter M A Calverley

N Engl J Med 2014 Oct 8;371(14):1285-94. Epub 2014 Sep 8.

The authors' affiliations are listed in the Appendix.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1056/NEJMoa1407154DOI Listing
October 2014

Non-emphysematous chronic obstructive pulmonary disease is associated with diabetes mellitus.

Authors:
Craig P Hersh Barry J Make David A Lynch R Graham Barr Russell P Bowler Peter M A Calverley Peter J Castaldi Michael H Cho Harvey O Coxson Dawn L DeMeo Marilyn G Foreman MeiLan K Han Benjamin J Harshfield John E Hokanson Sharon Lutz Joe W Ramsdell Elizabeth A Regan Stephen I Rennard Joyce D Schroeder Frank C Sciurba Robert M Steiner Ruth Tal-Singer Edwin van Beek Edwin K Silverman James D Crapo

BMC Pulm Med 2014 Oct 24;14:164. Epub 2014 Oct 24.

Channing Division of Network Medicine, Boston, MA, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1186/1471-2466-14-164DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4216374PMC
October 2014

Evaluating the role of inflammation in chronic airways disease: the ERICA study.

Authors:
Divya Mohan Nichola S Gale Carmel M McEniery Charlotte E Bolton John R Cockcroft William MacNee Jonathan Fuld David A Lomas Peter M A Calverley Dennis J Shale Bruce E Miller Ian B Wilkinson Ruth Tal-Singer Michael I Polkey

COPD 2014 Sep 15;11(5):552-9. Epub 2014 May 15.

1NIHR Respiratory Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust and Imperial College, London, UK.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.3109/15412555.2014.898031DOI Listing
September 2014

Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis.

Authors:
Mona Bafadhel Lisa Davies Peter M A Calverley Shawn D Aaron Christopher E Brightling Ian D Pavord

Eur Respir J 2014 Sep 12;44(3):789-91. Epub 2014 Jun 12.

Dept of Respiratory Medicine, Nuffield Dept of Medicine, University of Oxford, Oxford, UK.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1183/09031936.00062614DOI Listing
September 2014

Something better for the weekend?

Authors:
Peter M A Calverley

Eur Respir J 2014 Sep;44(3):568-9

University Hospital Aintree, Clinical Science, Liverpool, UK

View Article

Download full-text PDF

 Source
http://erj.ersjournals.com/cgi/doi/10.1183/09031936.00102114
Publisher Site
http://dx.doi.org/10.1183/09031936.00102114DOI Listing
September 2014

Treating COPD in the real world.

Authors:
Peter M A Calverley

JAMA 2014 Sep;312(11):1101-2

Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, England.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1001/jama.2014.11322DOI Listing
September 2014

Changes in body composition in patients with chronic obstructive pulmonary disease: do they influence patient-related outcomes?

Authors:
Erica P A Rutten Peter M A Calverley Richard Casaburi Alvar Agusti Per Bakke Bartolome Celli Harvey O Coxson Courtney Crim David A Lomas William Macnee Bruce E Miller Stephan I Rennard Paul D Scanlon Edwin K Silverman Ruth Tal-Singer Jørgen Vestbo Michael L Watkins Emiel F M Wouters

Ann Nutr Metab 2013 7;63(3):239-47. Epub 2013 Nov 7.

Center of Expertise for Chronic Organ Failure (Ciro+), Horn, The Netherlands.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1159/000353211DOI Listing
August 2014

Coronary artery calcification is increased in patients with COPD and associated with increased morbidity and mortality.

Authors:
Michelle C Williams John T Murchison Lisa D Edwards Alvar Agustí Per Bakke Peter M A Calverley Bartolome Celli Harvey O Coxson Courtney Crim David A Lomas Bruce E Miller Steve Rennard Edwin K Silverman Ruth Tal-Singer Jørgen Vestbo Emiel Wouters Julie C Yates Edwin J R van Beek David E Newby William MacNee

Thorax 2014 Aug 28;69(8):718-23. Epub 2014 Jan 28.

Centre for Inflammation Research, University of Edinburgh, Edinburgh, UK.

View Article

Download full-text PDF

 Source
http://thorax.bmj.com/lookup/doi/10.1136/thoraxjnl-2012-2031
Publisher Site
http://dx.doi.org/10.1136/thoraxjnl-2012-203151DOI Listing
August 2014

Lessons from ECLIPSE: a review of COPD biomarkers.

Authors:
Rosa Faner Ruth Tal-Singer John H Riley Bartolomé Celli Jørgen Vestbo William MacNee Per Bakke Peter M A Calverley Harvey Coxson Courtney Crim Lisa D Edwards Nick Locantore David A Lomas Bruce E Miller Stephen I Rennard Emiel F M Wouters Julie C Yates Edwin K Silverman Alvar Agusti

Thorax 2014 Jul 5;69(7):666-72. Epub 2013 Dec 5.

Fundació Investigació Sanitària Illes Balears (FISIB), Ciber Enfermedades Respiratorias (CIBERES), Barcelona, Catalunya, Spain Thorax Institute, Hospital Clinic, IDIBAPS, Univ. Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1136/thoraxjnl-2013-204778DOI Listing
July 2014

Use of inhaled corticosteroids in patients with COPD and the risk of TB and influenza: A systematic review and meta-analysis of randomized controlled trials. a systematic review and meta-analysis of randomized controlled trials.

Authors:
Yaa-Hui Dong Chia-Hsuin Chang Fe-Lin Lin Wu Li-Jiuan Shen Peter M A Calverley Claes-Göran Löfdahl Mei-Shu Lai Donald A Mahler

Chest 2014 Jun;145(6):1286-1297

Section of Pulmonary and Critical Care Medicine, Geisel School of Medicine at Dartmouth, Hanover, NH; Dartmouth-Hitchcock Medical Center, Lebanon, NH.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1378/chest.13-2137DOI Listing
June 2014

Should we view chronic obstructive pulmonary disease differently after ECLIPSE? A clinical perspective from the study team.

Authors:
Jørgen Vestbo Alvar Agusti Emiel F M Wouters Per Bakke Peter M A Calverley Bartolome Celli Harvey Coxson Courtney Crim Lisa D Edwards Nicholas Locantore David A Lomas William MacNee Bruce Miller Stephen I Rennard Edwin K Silverman Julie C Yates Ruth Tal-Singer

Am J Respir Crit Care Med 2014 May;189(9):1022-30

1 Department of Respiratory Medicine, Odense University Hospital, and Clinical Institute, University of Southern Denmark, Odense, Denmark.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1164/rccm.201311-2006PPDOI Listing
May 2014

Stepwise withdrawal of inhaled corticosteroids in COPD patients receiving dual bronchodilation: WISDOM study design and rationale.

Authors:
Helgo Magnussen Henrik Watz Anne Kirsten Marc Decramer Ronald Dahl Peter M A Calverley Lesley Towse Helen Finnigan Kay Tetzlaff Bernd Disse

Respir Med 2014 Apr 15;108(4):593-9. Epub 2014 Jan 15.

Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany.

View Article

Download full-text PDF

 Source
https://linkinghub.elsevier.com/retrieve/pii/S09546111140002
Publisher Site
http://dx.doi.org/10.1016/j.rmed.2014.01.002DOI Listing
April 2014

Pooled subpopulation analyses of the effects of roflumilast on exacerbations and lung function in COPD.

Authors:
Nicola A Hanania Peter M A Calverley Mark T Dransfield Jill P Karpel Manja Brose Haiyuan Zhu Udo-Michael Goehring Paul Rowe

Respir Med 2014 Feb 30;108(2):366-75. Epub 2013 Sep 30.

Forest Research Institute, Jersey City, NJ 07311, USA.

View Article

Download full-text PDF

 Source
https://linkinghub.elsevier.com/retrieve/pii/S09546111130038
Publisher Site
http://dx.doi.org/10.1016/j.rmed.2013.09.018DOI Listing
February 2014

Response.

Authors:
Jadwiga A Wedzicha Klaus F Rabe Fernando J Martinez Dirk Bredenbröker Manja Brose Udo-Michael Goehring Peter M A Calverley

Chest 2014 Feb;145(2):428

University of Liverpool, Liverpool, England.

View Article

Download full-text PDF

 Source
https://linkinghub.elsevier.com/retrieve/pii/S00123692153420
Publisher Site
http://dx.doi.org/10.1378/chest.13-2535DOI Listing
February 2014

New treatments for COPD: many miles still to go.

Authors:
Peter M A Calverley

Lancet Respir Med 2014 Jan 5;2(1):6-7. Epub 2013 Dec 5.

Clinical Science Centre, University Hospital Aintree, Longmoor Lane, Liverpool, L9 7AL, UK. Electronic address:

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/S2213-2600(13)70242-XDOI Listing
January 2014

Measuring habitual physical activity in adults with cystic fibrosis.

Authors:
Daniela Savi Serena Quattrucci Mattia Internullo Riccardo V De Biase Peter M A Calverley Paolo Palange

Respir Med 2013 Dec 22;107(12):1888-94. Epub 2013 Sep 22.

Department of Pediatrics and Pediatric Neurology, Cystic Fibrosis Center, Sapienza University of Rome, Viale Regina Elena, 324, Rome 00185, Italy. Electronic address:

View Article

Download full-text PDF

 Source
https://linkinghub.elsevier.com/retrieve/pii/S09546111130037
Publisher Site
http://dx.doi.org/10.1016/j.rmed.2013.09.012DOI Listing
December 2013

Putting noninvasive lung mechanics into context.

Authors:
Peter M A Calverley Ramon Farre

Eur Respir J 2013 Dec;42(6):1435-7

University of Liverpool, Liverpool, UK.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1183/09031936.00093413DOI Listing
December 2013

The ABCD of GOLD made clear.

Authors:
Peter M A Calverley

Eur Respir J 2013 Nov;42(5):1163-5

University of Liverpool, Dept of Clinical Sciences, University Hospital Aintree, Liverpool, UK.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1183/09031936.00117413DOI Listing
November 2013

Cardiovascular safety in patients receiving roflumilast for the treatment of COPD.

Authors:
William B White Glen E Cooke Peter R Kowey Peter M A Calverley Dirk Bredenbröker Udo-Michael Goehring Haiyuan Zhu Hassan Lakkis Hans Mosberg Paul Rowe Klaus F Rabe

Chest 2013 Sep;144(3):758-765

University Kiel and Lung Clinic Grosshansdorf, members of the German Center for Lung Research, Grosshansdorf, Germany.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1378/chest.12-2332DOI Listing
September 2013

Number needed to treat in COPD: exacerbations versus pneumonias.

Authors:
Oliver N Keene Antonio Anzueto Gary T Ferguson Peter M A Calverley

Thorax 2013 Sep 15;68(9):882. Epub 2013 Mar 15.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1136/thoraxjnl-2013-203403DOI Listing
September 2013

Characteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohort.

Authors:
Alvar Agusti Lisa D Edwards Bartolomé Celli William Macnee Peter M A Calverley Hana Müllerova David A Lomas Emiel Wouters Per Bakke Steve Rennard Courtney Crim Bruce E Miller Harvey O Coxson Julie C Yates Ruth Tal-Singer Jørgen Vestbo

Eur Respir J 2013 Sep 13;42(3):636-46. Epub 2013 Jun 13.

Hospital Clinic, IDIBAPS, Universitat de Barcelona and CIBER Enfermedades Respiratorias, FISIB, Mallorca, Spain.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1183/09031936.00195212DOI Listing
September 2013

Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort.

Authors:
Joy Miller Lisa D Edwards Alvar Agustí Per Bakke Peter M A Calverley Bartolome Celli Harvey O Coxson Courtney Crim David A Lomas Bruce E Miller Steve Rennard Edwin K Silverman Ruth Tal-Singer Jørgen Vestbo Emiel Wouters Julie C Yates William Macnee

Respir Med 2013 Sep 19;107(9):1376-84. Epub 2013 Jun 19.

Queen's Medical Research Institute, University of Edinburgh & Royal Infirmary, Edinburgh, UK.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.rmed.2013.05.001DOI Listing
September 2013

Bronchodilator reversibility in chronic obstructive pulmonary disease: use and limitations.

Authors:
Peter M A Calverley Paul Albert Paul P Walker

Lancet Respir Med 2013 Sep 18;1(7):564-73. Epub 2013 Jun 18.

Aintree Chest Centre, University Hospital Aintree, Liverpool, UK.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/S2213-2600(13)70086-9DOI Listing
September 2013

Chronic obstructive pulmonary disease and exacerbations: patient insights from the global Hidden Depths of COPD survey.

Authors:
Neil Barnes Peter M A Calverley Alan Kaplan Klaus F Rabe

BMC Pulm Med 2013 Aug 23;13:54. Epub 2013 Aug 23.

Department of Respiratory Medicine, London Chest Hospital (Barts Health NHS Trust), Bonner Road, London E2 9JX, UK.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1186/1471-2466-13-54DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765923PMC
August 2013

Factors associated with change in exacerbation frequency in COPD.

Authors:
Gavin C Donaldson Hanna Müllerova Nicholas Locantore John R Hurst Peter M A Calverley Jorgen Vestbo Antonio Anzueto Jadwiga A Wedzicha

Respir Res 2013 Jul 30;14:79. Epub 2013 Jul 30.

Centre for Respiratory Medicine, UCL Medical School, Royal Free Campus, Rowland Hill Street Hampstead, London NW3 2PF, UK.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1186/1465-9921-14-79DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3733814PMC
July 2013

Fluticasone furoate and vilanterol for COPD - authors' reply.

Authors:
Mark T Dransfield Sally Lettis Frank Barnhart Courtney Crim Peter M A Calverley

Lancet Respir Med 2013 Jul 8;1(5):e21-2. Epub 2013 Jul 8.

University of Liverpool, Liverpool, UK.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/S2213-2600(13)70125-5DOI Listing
July 2013

The Study to Understand Mortality and Morbidity in COPD (SUMMIT) study protocol.

Authors:
Jørgen Vestbo Julie Anderson Robert D Brook Peter M A Calverley Bartolome R Celli Courtney Crim Brett Haumann Fernando J Martinez Julie Yates David E Newby

Eur Respir J 2013 May 27;41(5):1017-22. Epub 2012 Sep 27.

Dept of Respiratory Medicine J, Odense University Hospital and University of Southern Denmark, Odense, Denmark.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1183/09031936.00087312DOI Listing
May 2013

Efficacy of roflumilast in the COPD frequent exacerbator phenotype.

Authors:
Jadwiga A Wedzicha Klaus F Rabe Fernando J Martinez Dirk Bredenbröker Manja Brose Udo-Michael Goehring Peter M A Calverley

Chest 2013 May;143(5):1302-1311

School of Clinical Sciences, University Hospital Aintree, Liverpool, England; University Kiel, Kiel.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1378/chest.12-1489DOI Listing
May 2013

Once-daily inhaled fluticasone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: two replicate double-blind, parallel-group, randomised controlled trials.

Authors:
Mark T Dransfield Jean Bourbeau Paul W Jones Nicola A Hanania Donald A Mahler Jørgen Vestbo Andrew Wachtel Fernando J Martinez Frank Barnhart Lisa Sanford Sally Lettis Courtney Crim Peter M A Calverley

Lancet Respir Med 2013 May 12;1(3):210-23. Epub 2013 Apr 12.

University of Liverpool, Liverpool, UK. Electronic address:

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/S2213-2600(13)70040-7DOI Listing
May 2013

Fluticasone furoate/vilanterol (100/25; 200/25 μg) improves lung function in COPD: a randomised trial.

Authors:
Fernando J Martinez Joseph Boscia Gregory Feldman Catherine Scott-Wilson Sally Kilbride Leonardo Fabbri Courtney Crim Peter M A Calverley

Respir Med 2013 Apr 16;107(4):550-9. Epub 2013 Jan 16.

University of Michigan, Ann Arbor, MI, USA.

View Article

Download full-text PDF

 Source
https://linkinghub.elsevier.com/retrieve/pii/S09546111120050
Publisher Site
http://dx.doi.org/10.1016/j.rmed.2012.12.016DOI Listing
April 2013

The effect of posture on asynchronous chest wall movement in COPD.

Authors:
Rita Priori Andrea Aliverti André L Albuquerque Marco Quaranta Paul Albert Peter M A Calverley

J Appl Physiol (1985) 2013 Apr 14;114(8):1066-75. Epub 2013 Feb 14.

Dipartimento di Elettronica, Informazione e Bioingegneria, Politecnico di Milano, Milano, Italy.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1152/japplphysiol.00414.2012DOI Listing
April 2013

Six-minute-walk test in chronic obstructive pulmonary disease: minimal clinically important difference for death or hospitalization.

Authors:
Michael I Polkey Martijn A Spruit Lisa D Edwards Michael L Watkins Victor Pinto-Plata Jørgen Vestbo Peter M A Calverley Ruth Tal-Singer Alvar Agustí Per S Bakke Harvey O Coxson David A Lomas William MacNee Stephen Rennard Edwin K Silverman Bruce E Miller Courtney Crim Julie Yates Emiel F M Wouters Bartolome Celli

Am J Respir Crit Care Med 2013 Feb 21;187(4):382-6. Epub 2012 Dec 21.

NIHR Respiratory Biomedical Research Unit at the Royal Brompton Hospital and Imperial College London, London, United Kingdom.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1164/rccm.201209-1596OCDOI Listing
February 2013

Does roflumilast decrease exacerbations in severe COPD patients not controlled by inhaled combination therapy? The REACT study protocol.

Authors:
Peter M A Calverley Fernando J Martinez Leonardo M Fabbri Udo-Michael Goehring Klaus F Rabe

Int J Chron Obstruct Pulmon Dis 2012 20;7:375-82. Epub 2012 Jun 20.

Clinical Science Center, University Hospital Aintree, Liverpool, United Kingdom.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.2147/COPD.S31100DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3393336PMC
December 2012

The effect of continuous positive airway pressure usage on sleepiness in obstructive sleep apnoea: real effects or expectation of benefit?

Authors:
Megan R Crawford Delwyn J Bartlett Steven R Coughlin Craig L Phillips Alister M Neill Colin A Espie George C Dungan John P H Wilding Peter M A Calverley Ronald R Grunstein Nathaniel S Marshall

Thorax 2012 Oct 26;67(10):920-4. Epub 2012 May 26.

NHMRC Centre for Integrated Research and Understanding of Sleep, Woolcock Institute of Medical Research, Sydney Medical School, University of Sydney, Sydney, Australia.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1136/thoraxjnl-2012-201622DOI Listing
October 2012

Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype.

Authors:
Alvar Agustí Lisa D Edwards Stephen I Rennard William MacNee Ruth Tal-Singer Bruce E Miller Jørgen Vestbo David A Lomas Peter M A Calverley Emiel Wouters Courtney Crim Julie C Yates Edwin K Silverman Harvey O Coxson Per Bakke Ruth J Mayer Bartolome Celli

PLoS One 2012 18;7(5):e37483. Epub 2012 May 18.

Thorax Institute, Hospital Clinic, Institut d'investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona and Centro de investigación en red de enfermedades respiratorias (CIBERES), Barcelona, Spain.

View Article

Download full-text PDF

 Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0037483PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356313PMC
September 2012